申请人:KemPharm, Inc.
公开号:US10010615B2
公开(公告)日:2018-07-03
The presently described technology provides a novel class of prodrugs of quetiapine that can be synthesized by chemically conjugating amino acids. The present technology also provides methods of treating patients, pharmaceutical compositions and methods of synthesizing conjugates of the present technology.
本技术提供了一类新型的喹硫平原药,可以通过化学合成氨基酸的方法合成。本技术还提供了治疗病人的方法、药物组合物和合成本技术共轭物的方法。